ATE374768T1 - Indole-3-carbonsaüreamide als glucokinase (gk) aktivatoren - Google Patents

Indole-3-carbonsaüreamide als glucokinase (gk) aktivatoren

Info

Publication number
ATE374768T1
ATE374768T1 AT03750648T AT03750648T ATE374768T1 AT E374768 T1 ATE374768 T1 AT E374768T1 AT 03750648 T AT03750648 T AT 03750648T AT 03750648 T AT03750648 T AT 03750648T AT E374768 T1 ATE374768 T1 AT E374768T1
Authority
AT
Austria
Prior art keywords
glucokinase
activators
indole
carbonic acid
acid amides
Prior art date
Application number
AT03750648T
Other languages
English (en)
Inventor
Wendy Corbett
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE374768T1 publication Critical patent/ATE374768T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
AT03750648T 2002-10-03 2003-09-26 Indole-3-carbonsaüreamide als glucokinase (gk) aktivatoren ATE374768T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41573702P 2002-10-03 2002-10-03

Publications (1)

Publication Number Publication Date
ATE374768T1 true ATE374768T1 (de) 2007-10-15

Family

ID=32069904

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03750648T ATE374768T1 (de) 2002-10-03 2003-09-26 Indole-3-carbonsaüreamide als glucokinase (gk) aktivatoren

Country Status (29)

Country Link
US (1) US6881844B2 (de)
EP (1) EP1549638B1 (de)
JP (1) JP4390704B2 (de)
KR (1) KR100646486B1 (de)
CN (1) CN100348596C (de)
AR (1) AR041467A1 (de)
AT (1) ATE374768T1 (de)
AU (1) AU2003270285B2 (de)
BR (1) BR0315047A (de)
CA (1) CA2499329C (de)
DE (1) DE60316709T2 (de)
DK (1) DK1549638T3 (de)
ES (1) ES2293005T3 (de)
HK (1) HK1083098A1 (de)
HR (1) HRP20050287A2 (de)
MX (1) MXPA05003391A (de)
MY (1) MY136764A (de)
NO (1) NO20051103L (de)
NZ (1) NZ538466A (de)
PA (1) PA8584001A1 (de)
PE (1) PE20050090A1 (de)
PL (1) PL375149A1 (de)
PT (1) PT1549638E (de)
RU (1) RU2309956C2 (de)
SI (1) SI1549638T1 (de)
TW (1) TW200413364A (de)
UY (1) UY28005A1 (de)
WO (1) WO2004031179A1 (de)
ZA (1) ZA200502619B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
CA2498089A1 (en) * 2002-10-03 2004-06-17 Novartis Ag Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
GB0226930D0 (en) * 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
EP1532980A1 (de) * 2003-11-24 2005-05-25 Novo Nordisk A/S N-Heteroaryl Indol-Carboxamide und deren analoga zur Vewendung als glucokinase Aktivatoren zur Behandlung von Diabetes
CA2561157A1 (en) 2004-04-02 2005-10-13 Novartis Ag Thiazolopyridine derivatives, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions
CA2560689C (en) 2004-04-02 2011-03-01 Novartis Ag Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful in the treatment of type 2 diabetes
EP2308839B1 (de) 2005-04-20 2017-03-01 Takeda Pharmaceutical Company Limited Kondensierte heterozyklische verbindungen
US7622492B2 (en) 2005-08-31 2009-11-24 Hoffmann-La Roche Inc. Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
EP1931337B1 (de) 2005-09-29 2013-10-23 Sanofi Phenyl- und pyridinyl-1,2,4-oxadiazolon-derivate, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutika
CA2623958C (en) 2005-09-30 2013-05-28 Banyu Pharmaceutical Co., Ltd. 2-heteroaryl-substituted indole derivative
GT200600429A (es) * 2005-09-30 2007-04-30 Compuestos organicos
GT200600428A (es) * 2005-09-30 2007-05-21 Compuestos organicos
JP2009013065A (ja) * 2005-10-14 2009-01-22 Astellas Pharma Inc 縮合へテロ環化合物
EP1948614A2 (de) * 2005-11-18 2008-07-30 Takeda San Diego, Inc. Glucokinaseaktivatoren
US7351706B2 (en) * 2006-01-05 2008-04-01 Hoffmann-La Roche Inc. Indol-3-yl-carbonyl-spiro-piperidine derivatives
WO2007104034A2 (en) 2006-03-08 2007-09-13 Takeda San Diego, Inc. Glucokinase activators
EP1849785A1 (de) 2006-04-28 2007-10-31 Neuropharma, S.A. N-(2-Thiazolyl)-Amid-Derivative als GSK-3 Inhibitoren
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
ATE522518T1 (de) * 2006-05-31 2011-09-15 Takeda San Diego Inc Indazol- und isoindolderivate als glucokinaseaktivierende stoffe
US8410087B2 (en) 2006-10-19 2013-04-02 Takeda Pharmaceutical Company Limited Indole compound
WO2008074694A1 (en) * 2006-12-20 2008-06-26 F. Hoffmann-La Roche Ag Crystallization of glucokinase activators
JP5419706B2 (ja) 2006-12-20 2014-02-19 タケダ カリフォルニア インコーポレイテッド グルコキナーゼアクチベーター
WO2008116107A2 (en) 2007-03-21 2008-09-25 Takeda San Diego, Inc. Piperazine derivatives as glucokinase activators
CA2691512A1 (en) * 2007-08-10 2009-02-19 H. Lundbeck A/S Heteroaryl amide analogues
EP2294053B1 (de) * 2008-05-16 2016-01-06 Takeda California, Inc. Glucokinaseaktivatoren
US8835644B2 (en) 2009-03-20 2014-09-16 University Of Virginia Patent Foundation Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials
JP2011006366A (ja) 2009-06-26 2011-01-13 Sanwa Kagaku Kenkyusho Co Ltd 新規チオフェンカルボキサミド誘導体及びその医薬用途
US9333193B2 (en) 2010-09-20 2016-05-10 University Of Virginia Patent Foundation Compositions and methods for treating tuberculosis
CN103044310B (zh) * 2013-01-18 2015-02-04 贵阳医学院 二氢吲哚-3-乙酸衍生物、其制备方法以及在药物中的应用
WO2023067628A1 (en) * 2021-10-20 2023-04-27 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) A method for the preparation of indole-3-carboxylic acid derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2740686B1 (fr) 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
US6040321A (en) 1997-11-12 2000-03-21 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
US6262096B1 (en) 1997-11-12 2001-07-17 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
JP5278983B2 (ja) 1999-11-17 2013-09-04 塩野義製薬株式会社 アミド化合物の新規用途
KR100545431B1 (ko) 2000-12-06 2006-01-24 에프. 호프만-라 로슈 아게 축합된 이종방향족 글루코키나제 활성화제
US6433188B1 (en) 2000-12-06 2002-08-13 Wendy Lea Corbett Fused heteroaromatic glucokinase activators
US6482951B2 (en) 2000-12-13 2002-11-19 Hoffmann-La Roche Inc. Isoindolin-1-one glucokinase activators
KR100884877B1 (ko) * 2000-12-28 2009-02-23 다이이찌 세이야꾸 가부시기가이샤 Vla-4 저해제
UA77303C2 (en) * 2002-06-14 2006-11-15 Pfizer Derivatives of thienopyridines substituted by benzocondensed heteroarylamide useful as therapeutic agents, pharmaceutical compositions and methods for their use

Also Published As

Publication number Publication date
EP1549638A1 (de) 2005-07-06
RU2309956C2 (ru) 2007-11-10
KR20050046817A (ko) 2005-05-18
EP1549638B1 (de) 2007-10-03
NO20051103L (no) 2005-04-08
CN100348596C (zh) 2007-11-14
HRP20050287A2 (en) 2006-12-31
JP4390704B2 (ja) 2009-12-24
CA2499329A1 (en) 2004-04-15
PT1549638E (pt) 2007-12-11
MY136764A (en) 2008-11-28
CN1688574A (zh) 2005-10-26
HK1083098A1 (en) 2006-06-23
DE60316709D1 (de) 2007-11-15
TW200413364A (en) 2004-08-01
ES2293005T3 (es) 2008-03-16
BR0315047A (pt) 2005-08-23
PA8584001A1 (es) 2004-11-02
US20040067939A1 (en) 2004-04-08
AU2003270285A1 (en) 2004-04-23
DK1549638T3 (da) 2008-01-21
JP2006504707A (ja) 2006-02-09
US6881844B2 (en) 2005-04-19
AU2003270285B2 (en) 2007-04-26
SI1549638T1 (sl) 2008-02-29
MXPA05003391A (es) 2005-06-22
WO2004031179A1 (en) 2004-04-15
CA2499329C (en) 2009-04-21
DE60316709T2 (de) 2008-07-17
PL375149A1 (en) 2005-11-28
KR100646486B1 (ko) 2006-11-15
PE20050090A1 (es) 2005-02-28
ZA200502619B (en) 2006-03-29
NZ538466A (en) 2007-05-31
RU2005113719A (ru) 2006-02-27
UY28005A1 (es) 2004-04-30
AR041467A1 (es) 2005-05-18

Similar Documents

Publication Publication Date Title
ATE374768T1 (de) Indole-3-carbonsaüreamide als glucokinase (gk) aktivatoren
NO20043116L (no) Amidderivater som GK-aktivatorer
DK1572670T3 (da) 5-substitueret-pyrazin eller -pyridin-glucokinaseaktivatorer
ATE419250T1 (de) 2-cyanopyrrolidincarbonsäureamide als dipeptidylpeptidase-iv-inhibitoren
DK1501815T3 (da) Substituerede phenylacetamider og anvendelse deraf som glucokinaseaktivatorer
DE60305903D1 (de) Tropanderivative als ccr5-modulatoren
DE60336538D1 (de) Stabilisiervorrichtung
ATE427953T1 (de) Fondaparinux- natrium zusammenstellung von hoher reinheit
DK1572229T3 (da) Stabilt terapeutisk fibrinogen
ATE402700T1 (de) Glycinamid-derivate als raf-kinase-hemmer
ATE331714T1 (de) Cyclopropylthienylcarbonsäureamide als fungizide
ATE421515T1 (de) Carbonsäureamide
ITMI20020198A0 (it) (per)aloeteri
ATE299491T1 (de) Benzoltricarbonsäureamide als aktivatoren des insulinrezeptors
NO20044364L (no) Hydroksykarbamimidoyl-2-hydroksy-benzensulfonamidderivat-krystaller
DE60308058D1 (de) Sauerstoffversorgungsanlage
UA7363S (uk) Комплект етикеток для вина
UA6967S (uk) Комплект етикеток для вина
UA6615S (uk) Комплект етикеток вмістини для фіточаю
ITLE20020026A1 (it) Compensatore di ossigeno
SE0200175D0 (sv) Kontrollapparat
UA7065S (uk) Комплект етикеток до пляшки
UA7405S (uk) Комплект етикеток до пляшки
UA6912S (uk) Комплект етикеток до пляшки
UA6708S (uk) Комплект етикеток до пляшки

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1549638

Country of ref document: EP

REN Ceased due to non-payment of the annual fee